Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World’s Most Innovative and Comprehensive Orthopaedics Business

April 27, 2011 By Bio-Medicine.Org

NEW BRUNSWICK, N.J. and WEST CHESTER, Pa., April 27, 2011
/PRNewswire/ — Johnson & Johnson (NYSE:
JNJ
), the world’s most comprehensive and broadly-based
manufacturer of health care products, and Synthes, Inc.
(SWX:SYST.VX), a premier global manufacturer of orthopaedic
devices, today announced that they have entered into a definitive
agreement whereby Johnson & Johnson will acquire Synthes for
CHF159 per share, or $21.3 billion.  Upon completion of this
transaction, Synthes and the DePuy Companies of Johnson &
Johnson together will comprise the largest business within the
Medical Devices and Diagnostics segment of Johnson & Johnson.
 

Under the terms of the agreement, each share of Synthes common
stock, subject to certain conditions, will be exchanged for
CHF55.65 in cash and CHF103.35 in Johnson & Johnson common
stock. The transaction has an estimated net acquisition cost of
$19.3 billion as of the close of business on April 26, 2011, based
on Synthes approximately 119.5 million fully diluted shares
outstanding and approximately $2 billion in cash on hand as of
signing.

The Boards of Directors of Johnson & Johnson and Synthes
have each approved the transaction. Dr. Hansjoerg Wyss, Synthes
founder and Chairman of the Board, and related parties have agreed
to vote shares representing not less than 33% of Synthes common
stock in support of the transaction.

DePuy offers one of the most diverse orthopaedics portfolios in
the industry, while Synthes is recognized for its innovations in
trauma, spine, cranio-maxillofacial and power tools.
 Together, the companies will offer surgeons and patients a
unique breadth and depth of technology and service worldwide to
meet their orthopaedic needs.

“DePuy and Synthes together will create the most innovative and
comprehensive orthopaedics business in the world and enable us to
bett

‘/>”/>

SOURCE

Related Articles Read More >

UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial
CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’
Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices

DeviceTalks Weekly.

August 5, 2022
DTW Medtronic's Greg Smith lays out supply chain strategies
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech